2026年4月23日 下午4:21 UTC 更新于1小时前 / 路透社
节点运行失败
2024年11月24日摄于美国华盛顿联邦贸易委员会（FTC）总部的标识。路透社/伯努瓦·泰西耶/档案照片
（路透社4月23日电）根据周四提交的法庭文件，美国联邦贸易委员会将就其针对一家私募股权投资组合公司的案件达成和解。该委员会称，这家公司被用于收购德克萨斯州的麻醉诊疗机构并抬高价格。
重要性
美国联邦贸易委员会在拜登政府任期内起诉了美国麻醉伙伴公司（USAP），这是反垄断监管机构打击私募股权投资“打包收购”的一项重大举措。所谓打包收购，即收购大量小型企业，据称此举会削弱整个行业的竞争。私募股权投资机构将密切关注尚未公开的和解条款。
即刻订阅《每日案卷》新闻简报，将最新法律新闻发送至您的收件箱，开启您的晨间资讯。在此注册。
广告 · 滚动继续阅读
背景
特朗普政府时期的联邦贸易委员会将医疗保健列为优先工作领域，但同时强调，只要条款足以消除相关问题，该机构愿意达成和解。
创立美国麻醉伙伴公司的私募股权投资公司威尔士、卡森、安德森与斯托公司曾被联邦贸易委员会起诉，但该公司在赢得驳回相关指控的动议后，与该机构达成了和解。
数据一览
联邦贸易委员会表示，此次打包收购涉及十余家麻醉诊疗机构、1000名医生以及750名护士。
回应
联邦贸易委员会表示，此次和解目前处于保密状态，“以方便美国麻醉伙伴公司必须开展的谈判”，但称该协议将“恢复竞争性市场结构，且将符合联邦贸易委员会长期以来的和解最佳实践标准”。该机构表示，如果美国麻醉伙伴公司未能完全执行和解协议，联邦贸易委员会将重启诉讼。
广告 · 滚动继续阅读
美国麻醉伙伴公司主席斯科特·霍利迪在一份声明中表示，尽管公司认为自己在德克萨斯州的运营一直合规，但“现在解决此事十分重要，这样美国麻醉伙伴公司才能继续专注于提供高质量的麻醉服务”。
乔迪·戈多伊 纽约报道；罗德·尼克尔与保罗·西mao 编辑
我们的准则：汤森路透信托原则。
US FTC settles case against anesthesia company
April 23, 2026 4:21 PM UTC Updated 1 hour ago / Reuters
节点运行失败
A view of signage at the Federal Trade Commission (FTC) headquarters in Washington, D.C., U.S., November 24, 2024. REUTERS/Benoit Tessier/File Photo
April 23 (Reuters) – The U.S. Federal Trade Commission is settling its case against a private equity portfolio company it says was used to buy up anesthesiology practices and raise prices in Texas, according to court documents filed on Thursday.
WHY IT’S IMPORTANT
The FTC sued U.S. Anesthesia Partners (USAP) under the Biden administration in a major move by antitrust regulators to tackle private equity rollups, or purchases of many small businesses that allegedly decrease competition across an industry. Private equity firms will look closely at the terms of the settlement, which have not yet been made public.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Advertisement · Scroll to continue
CONTEXT
The FTC under President Donald Trump has made healthcare a priority, but at the same time has emphasized it is willing to settle on terms it finds adequate to remove any problems.
Private equity firm Welsh, Carson, Anderson & Stowe, which created USAP, was sued by the FTC, but settled with the agency after winning a bid to dismiss claims against it.
BY THE NUMBERS
The FTC said the rollup involved more than a dozen anesthesiology practices, 1,000 doctors, and 750 nurses.
THE RESPONSE
The FTC said the settlement is currently confidential “to facilitate the negotiations USAP must undertake,” but that the deal would “restore a competitive market structure and will be consistent with longstanding FTC settlement best practices.” If USAP fails to fully execute the settlement, the FTC will resume its case, the agency said.
Advertisement · Scroll to continue
USAP Chairman Scott Holliday said in a statement that while the company believes it has operated responsibly in Texas, “it was important to resolve this now so that USAP can remain laser-focused on providing high-quality anesthesia services.”
Reporting by Jody Godoy in New York; Editing by Rod Nickel and Paul Simao
Our Standards: The Thomson Reuters Trust Principles.
发表回复